Log in using OpenID

Global Oncology Molecular Diagnostics Market | Size | Share | Trends

Big Market Research has announced a new Report Package "Global Oncology Molecular Diagnostics Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at:
Global Oncology Molecular Diagnostics Market
Report Description
About oncology molecular diagnostics
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics.
It is a technique used for analyzing biological markers in proteome and genome. Molecular
diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics,
and human leukocyte antigen typing.
Oncology molecular diagnostics is a major application of molecular biology and is
increasingly used for cancer screening, therapy selection, diagnosis, and relapse
monitoring. Some of the major that are diagnosed and treated by molecular diagnostics
are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung,
and endometrial cancers.
Get complete Report @
The global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the
period 2014-2019.
Report Description
Covered in this report
The report covers the current scenario and the growth prospects of the global oncology
molecular diagnostics market for the period of 2015-2019. To calculate the market size, the
report considers revenue generated through the sales of diagnostics assay kits and
instruments for cancers, which include:
• Breast
• Colorectal
• Prostate
• Others (including lung and cervical cancers)
Enquire about this report @
Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers APAC,
Europe, Latin America, MEA, and North America; it also covers the landscape of the market
and its growth prospects in the coming years. The report includes a discussion of the key
vendors operating in this market.
Report Description
Key regions
• Europe
• Latin America
• North America
Key vendors
• Abbott Diagnostics
• Becton, Dickinson and Company
• Roche Diagnostics
Other prominent vendors
• Agendia
• Angsana Molecular and Diagnostics
• Asuragen
• Autogenomics
• Beckman Coulter
• bioMérieux
Report Description
• bioTheranostics (Formerly AviaraDx)
• Cangen Biotechnologies
• Cepheid
• Diagnocure
• Epigenomics
• Eragen
• EXACT Sciences
• Exiqon
• GeneNews
• Genera Biosystems
• Genomic Health
• Health Discovery
• HTG Molecular
• Hologic
• Innogenetics
• Intergenetics
• Kreatech Holding
• Myriad Genetics
• Nanosphere
• NorDiag
Report Description
Market driver
• Increase in demand for personalized medicines
• For a full, detailed list, view our report
Market challenge
• Ethical, privacy, and practical issues
• For a full, detailed list, view our report
Market trend
• Advances in mass spectrometry
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Table of Contents
1. Executive summary
2. Scope of the report
3. Market research methodology
4. Introduction
5 Cancer statistics
6 Market landscape
7 Reimbursement and coverage: An overview
8 Molecular diagnostic products: Pricing scenario
9 Market segmentation by cancer type
10 Geographical segmentation
11: Market drivers
12: Impact of drivers
13: Market challenges
14: Impact of drivers and challenges
15: Market trends
16: Vendor landscape
Visit us at :
Stay With Us:
TELEPHONE: + 1-800-910-6452
[email protected]
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Report inappropriate content